Dabrafenib from ABBEXA LTD

Search, find, compare suppliers for Dabrafenib products.

Edit 
Product NameDabrafenib
DescriptionDabrafenib (GSK2118436) is a small molecule which can act as a B-Raf mutant inhibitor. It is provided as an off-white powder.

This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Autophagy.
This product may be of interest in the following research areas and diseases: Cellular stress, Cell death, Cancer.
This product may act as a Coronavirus inhibitor: Inibits NEK9, which interacts with SARS-CoV-2 Nsp9.

Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. Purity > 98% (TLC). Conforms to structure by NMR. MW: 519.6 g/mol
Size5 mg, 25 mg
Concentrationn/a
Applicationsn/a
Other NamesDabrafenib, Dabrafenib (GSK2118436), N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide, GSK2118436, 1195765-45-7
Gene, Accession, CAS #CAS: 1195765-45-7
Catalog #abx282416
Priceplease inquire
Order / More InfoDabrafenib from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Products

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.